S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q4 2023

Deep Track Capital

Periodo: Q4 2023 Β· Depositato: 2024-02-14
Vedi su SEC EDGAR β†—
AUM
$2.99B
Valore totale del portafoglio
Posizioni
60
Titoli dichiarati
Prima Posizione
INSM
5.5% $165.8M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2024-02-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
INSMINSMED INC$165.8M5.54%$29.94$111.60+272.8%
5.5%
SWTXSPRINGWORKS THERAPEUTICS INC$148.3M4.95%β€”β€”
5.0%
ITCIINTRA-CELLULAR THERAPIES INC$143.2M4.78%β€”β€”
4.8%
GHGUARDANT HEALTH INC$135.3M4.52%$26.51$167.98+533.6%
4.5%
ARGXARGENX SE$114.1M3.81%$381.00$939.68+146.6%
3.8%
CYTKCALLCYTOKINETICS INC$112.5M3.76%$84.12$86.49+2.8%
3.8%
ALKSALKERMES PLC$111.0M3.71%$28.62$54.58+90.7%
3.7%
PLRXPLIANT THERAPEUTICS INC$104.1M3.48%$17.96$1.17-93.5%
3.5%
DVAXDYNAVAX TECHNOLOGIES CORP$99.2M3.31%β€”β€”
3.3%
AXSMAXSOME THERAPEUTICS INC$79.6M2.66%$77.06$244.31+217.0%
2.7%
VRDNVIRIDIAN THERAPEUTICS INC$79.1M2.64%$22.35$19.40-13.2%
2.6%
AUTLAUTOLUS THERAPEUTICS PLC$76.4M2.55%$6.84$1.58-76.9%
2.5%
PACBPACIFIC BIOSCIENCES CALIF IN$68.7M2.29%$9.59$1.68-82.5%
2.3%
NTLAINTELLIA THERAPEUTICS INC$68.6M2.29%$30.82$17.56-43.0%
2.3%
TVTXTRAVERE THERAPEUTICS INC$66.3M2.21%$9.56$56.92+495.4%
2.2%
APGEAPOGEE THERAPEUTICS INC$64.9M2.17%$28.51$132.91+366.2%
2.2%
VRNAVERONA PHARMA PLC$63.4M2.12%β€”β€”
2.1%
IONSIONIS PHARMACEUTICALS INC$63.2M2.11%$52.87$81.80+54.7%
2.1%
BCYCBICYCLE THERAPEUTICS PLC$63.1M2.11%$18.44$4.35-76.4%
2.1%
GERNGERON CORP$62.4M2.08%$2.14$1.36-36.5%
2.1%
EDITEDITAS MEDICINE INC$55.4M1.85%$9.98$3.65-63.4%
1.9%
AMAMAMBRX BIOPHARMA INC$52.8M1.76%β€”β€”
1.8%
SRPTSAREPTA THERAPEUTICS INC$48.2M1.61%$96.21$19.28-80.0%
1.6%
TRMLTOURMALINE BIO INC$47.5M1.59%β€”β€”
1.6%
HLVXHILLEVAX INC$46.5M1.55%β€”β€”
1.6%
FDMT4D MOLECULAR THERAPEUTICS IN$46.3M1.55%$21.25$13.00-38.8%
1.6%
ABVXABIVAX SA$46.0M1.54%$10.80$144.65+1239.3%
1.5%
RAPTRAPT THERAPEUTICS INC$44.6M1.49%β€”β€”
1.5%
ANABANAPTYSBIO INC$43.6M1.46%$14.47$63.42+338.3%
1.5%
IMVTIMMUNOVANT INC$42.1M1.41%$41.39$38.79-6.3%
1.4%

AttivitΓ  Trimestre su Trimestre

Q4 2023 vs. Q3 2023

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
ARGXARGENX SE$114.1M+146.6%
CYTKCYTOKINETICS INC$112.5M+2.8%
AMAMAMBRX BIOPHARMA INC$52.8M
SRPTSAREPTA THERAPEUTICS INC$48.2M-80.0%
TRMLTOURMALINE BIO INC$47.5M
ABVXABIVAX SA$46.0M+1239.3%
SYRESPYRE THERAPEUTICS INC$42.0M
OCULOCULAR THERAPEUTIX INC$41.2M

Posizioni Chiuse (8)

TickerEmittenteNozionale
NVCRNOVOCURE LTD$40.4M
NBIXNEUROCRINE BIOSCIENCES INC$33.8M
BEAMBEAM THERAPEUTICS INC$24.4M
AMLXAMYLYX PHARMACEUTICALS INC$23.1M
BNTXBIONTECH SE$21.7M
MRNAMODERNA INC$20.7M
PNTPOINT BIOPHARMA GLOBAL INC$18.6M
MORFMORPHIC HLDG INC$10.8M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SRRKSCHOLAR ROCK HLDG CORP$16.5M+185.9%
AGIOAGIOS PHARMACEUTICALS INC$13.2M+151.7%
PRTAPUTPROTHENA CORP PLC$6.1M+100.0%
ANABANAPTYSBIO INC$19.5M+51.4%+338.3%
ANIPANI PHARMACEUTICALS INC$9.9M+50.0%
GHGUARDANT HEALTH INC$15.2M+23.5%+533.6%
VRDNVIRIDIAN THERAPEUTICS INC$33.6M+22.6%-13.2%
RAPTRAPT THERAPEUTICS INC$19.6M+19.6%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
JAZZJAZZ PHARMACEUTICALS PLC$-141.4M-95.8%
GPCRSTRUCTURE THERAPEUTICS INC$-84.3M-84.3%
IMVTIMMUNOVANT INC$-65.3M-64.3%-6.3%
IONSIONIS PHARMACEUTICALS INC$-65.4M-55.9%+54.7%
RLMDRELMADA THERAPEUTICS INC$-0.1M-28.0%
ITCIINTRA-CELLULAR THERAPIES INC$7.8M-23.1%
EDITEDITAS MEDICINE INC$0.1M-22.9%-63.4%
AUTLAUTOLUS THERAPEUTICS PLC$41.5M-20.9%-76.9%
← Torna agli Hedge Fund